|
Titre :
|
Differences in continuation rates and early removal between contraceptive and therapeutic use of the levonorgestrel-releasing intrauterine system 52 mg (2019)
|
|
Auteurs :
|
A.M. TEUNISSEN, Auteur ;
A.H.H. MERRY, Auteur ;
I.E.C. DEVIES, Auteur
|
|
Type de document :
|
Article : Article de périodique
|
|
Dans :
|
EUROPEAN JOURNAL OF CONTRACEPTION & REPRODUCTIVE HEALTH CARE (THE) (Vol. 24 - N° 6, December 2019)
|
|
Article en page(s) :
|
pp.449-456
|
|
Langues:
|
Anglais
|
|
Index. décimale :
|
232 (Contraception intra-utérine)
|
|
Catégories :
|
ASPECTS THERAPEUTIQUES
CONTRACEPTION HORMONALE
CONTRACEPTION INTRA-UTERINE
DISPOSITIF INTRA-UTERIN
DYSMENORRHEE
ETUDE DE COHORTE
PAYS-BAS
USAGE DU CONTRACEPTIF
|
|
Résumé :
|
Therapeutic use, having one child and a younger age are independent risk factors of early removal of the levenorgestrel-intrauterine system (LNG-IUS), in contrast with previous LNG-IUS use which is associated with a lower risk. In both the contraception group and the therapy group, the main reasons for LNG-IUS discontinuation are continuation with a new LNG-IUS, and no more need for an LNG-IUS (for contraception or therapy). An unacceptable bleeding pattern or adverse events are associated with the lowest continuation rates in both groups.
|
